Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200-Day Moving Average of $0.97

Shares of Biomerica, Inc. (NASDAQ:BMRA) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.97 and traded as low as $0.70. Biomerica shares last traded at $0.72, with a volume of 59,331 shares.

Biomerica Stock Performance

The company has a market capitalization of $12.19 million, a P/E ratio of -1.96 and a beta of -1.04. The firm’s fifty day moving average is $0.98 and its 200 day moving average is $0.97.

Biomerica (NASDAQ:BMRA) last released its earnings results on Friday, April 12th. The company reported ($0.11) EPS for the quarter. Biomerica had a negative net margin of 117.46% and a negative return on equity of 64.00%. The business had revenue of $1.02 million for the quarter.

Institutional Trading of Biomerica

A hedge fund recently raised its stake in Biomerica stock. Russell Investments Group Ltd. increased its stake in Biomerica, Inc. (NASDAQ:BMRA) by 15.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 201,563 shares of the company’s stock after buying an additional 26,288 shares during the period. Russell Investments Group Ltd. owned 1.20% of Biomerica worth $252,000 as of its most recent SEC filing. 22.28% of the stock is owned by institutional investors.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.